Hmd Biomedical Inc.
HMD Biomedical Inc., a leading name in the biomedical industry, is headquartered in Taiwan (TW) and operates extensively across Asia and beyond. Founded in 2002, the company has established itself as a pioneer in the development of innovative medical devices and diagnostic solutions, focusing on enhancing patient care and clinical efficiency. HMD Biomedical's core offerings include advanced point-of-care testing systems and high-quality laboratory equipment, distinguished by their precision and user-friendly design. The company has achieved significant milestones, including numerous certifications and partnerships that underscore its commitment to quality and innovation. With a strong market position, HMD Biomedical continues to drive advancements in healthcare technology, making a notable impact in the medical field.
DitchCarbon Score
How does Hmd Biomedical Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Machinery and Equipment industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Hmd Biomedical Inc.'s score of 10 is lower than 65% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Hmd Biomedical Inc.'s reported carbon emissions
Hmd Biomedical Inc., headquartered in Taiwan (TW), currently does not have available carbon emissions data for recent years, as no specific emissions figures have been provided. Consequently, there are no documented Scope 1, 2, or 3 emissions to report. In the absence of concrete emissions data, it is important to note that Hmd Biomedical Inc. has not outlined any specific reduction targets or climate commitments. This lack of information suggests that the company may still be in the early stages of developing a comprehensive climate strategy or may not have publicly disclosed its initiatives. As the industry increasingly prioritises sustainability and carbon neutrality, Hmd Biomedical Inc. may benefit from establishing clear climate commitments and reduction targets to align with global efforts in combating climate change.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Hmd Biomedical Inc. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
